全文获取类型
收费全文 | 1698篇 |
免费 | 115篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 45篇 |
妇产科学 | 74篇 |
基础医学 | 193篇 |
口腔科学 | 19篇 |
临床医学 | 147篇 |
内科学 | 422篇 |
皮肤病学 | 16篇 |
神经病学 | 102篇 |
特种医学 | 37篇 |
外科学 | 399篇 |
综合类 | 25篇 |
预防医学 | 64篇 |
眼科学 | 37篇 |
药学 | 95篇 |
中国医学 | 13篇 |
肿瘤学 | 133篇 |
出版年
2023年 | 12篇 |
2022年 | 9篇 |
2021年 | 50篇 |
2020年 | 36篇 |
2019年 | 44篇 |
2018年 | 59篇 |
2017年 | 37篇 |
2016年 | 47篇 |
2015年 | 51篇 |
2014年 | 75篇 |
2013年 | 83篇 |
2012年 | 110篇 |
2011年 | 121篇 |
2010年 | 67篇 |
2009年 | 53篇 |
2008年 | 101篇 |
2007年 | 95篇 |
2006年 | 102篇 |
2005年 | 106篇 |
2004年 | 93篇 |
2003年 | 69篇 |
2002年 | 66篇 |
2001年 | 43篇 |
2000年 | 36篇 |
1999年 | 26篇 |
1998年 | 15篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1995年 | 8篇 |
1993年 | 5篇 |
1992年 | 12篇 |
1991年 | 17篇 |
1990年 | 11篇 |
1989年 | 14篇 |
1988年 | 9篇 |
1987年 | 15篇 |
1986年 | 14篇 |
1985年 | 10篇 |
1984年 | 5篇 |
1983年 | 7篇 |
1979年 | 19篇 |
1978年 | 5篇 |
1977年 | 11篇 |
1976年 | 7篇 |
1975年 | 7篇 |
1974年 | 5篇 |
1973年 | 7篇 |
1972年 | 5篇 |
1971年 | 5篇 |
1970年 | 5篇 |
排序方式: 共有1836条查询结果,搜索用时 31 毫秒
1.
In this paper, we use optimal parameter selection technique to develop two models involving single‐vendor–multiple‐buyer supply chain, which are called the dynamic independent optimization (DIO) model and the dynamic synchronized cycles (DSC) model, respectively. These models are, respectively, similar to the traditional static independent policy model and the traditional static synchronized cycle model, except that the deterministic demands of the buyers in the above two static models are now being replaced by the stochastic demands satisfying a Wiener process, which have more real‐life applications. Similar to the above static synchronized cycles model, the synchronization of the supply chain in our DSC model is also achieved by scheduling the delivery days of the buyers and coordinating them with the vendor's production cycle. Finding the optimal expected system costs of the DIO model and the DSC model involves solving optimal parameter selection problems governed by ordinary differential equations, whose final times are continuous decision variables and discrete decision variables, respectively. Computational methods have been developed for solving these problems. Numerical results show that the coordinated policy is better than the independent optimization policy, in terms of minimizing the expected system cost of the entire supply chain. Sensitivity analysis is performed to test the effect of changing the cost coefficients and the value on the performances of these models, where is the ratio of the total mean demand rate of all the buyers over the vendor's production rate. 相似文献
2.
3.
Lu Ping Tan Geok Wee Tan Vijaya Mohan Sivanesan Siang Ling Goh Xun Jin Ng Chun Shen Lim Wee Ric Kim Taznim Begam Binti Mohd Mohidin Nor Soleha Mohd Dali Siew Hoon Ong Chun Ying Wong Halimuddin Sawali Yoke Yeow Yap Faridah Hassan Kin Choo Pua Cheng Eng Koay Ching Ching Ng Alan Soo-Beng Khoo the Malaysian Nasopharyngeal Carcinoma Study Group 《International journal of cancer. Journal international du cancer》2020,146(8):2336-2347
Nasopharyngeal carcinoma (NPC) is originated from the epithelial cells of nasopharynx, Epstein–Barr virus (EBV)-associated and has the highest incidence and mortality rates in Southeast Asia. Late presentation is a common issue and early detection could be the key to reduce the disease burden. Sensitivity of plasma EBV DNA, an established NPC biomarker, for Stage I NPC is controversial. Most newly reported NPC biomarkers have neither been externally validated nor compared to the established ones. This causes difficulty in planning for cost-effective early detection strategies. Our study systematically evaluated six established and four new biomarkers in NPC cases, population controls and hospital controls. We showed that BamHI-W 76 bp remains the most sensitive plasma biomarker, with 96.7% (29/30), 96.7% (58/60) and 97.4% (226/232) sensitivity to detect Stage I, early stage and all NPC, respectively. Its specificity was 94.2% (113/120) against population controls and 90.4% (113/125) against hospital controls. Diagnostic accuracy of BamHI-W 121 bp and ebv-miR-BART7-3p were validated. Hsa-miR-29a-3p and hsa-miR-103a-3p were not, possibly due to lower number of advanced stage NPC cases included in this subset. Decision tree modeling suggested that combination of BamHI-W 76 bp and VCA IgA or EA IgG may increase the specificity or sensitivity to detect NPC. EBNA1 99 bp could identify NPC patients with poor prognosis in early and advanced stage NPC. Our findings provided evidence for improvement in NPC screening strategies, covering considerations of opportunistic screening, combining biomarkers to increase sensitivity or specificity and testing biomarkers from single sampled specimen to avoid logistic problems of resampling. 相似文献
4.
5.
Kaleen N Hayes Vasily Giannakeas Andy Kin On Wong 《Journal of bone and mineral research》2020,35(12):2318-2326
Antiresorptive medications have been explored for treating knee osteoarthritis (OA); however, little data exist on the effects of today's more potent nitrogen-containing oral bisphosphonates on radiographic disease-progression in patients with varying disease-severity, especially those who are not overweight. The primary objective of this cohort study was to determine if the use of bisphosphonates is protective against 2-year radiographic-progression of knee OA in Osteoarthritis Initiative (OAI) participants, stratified by baseline radiographic disease status. Secondary objectives were to examine effects in non-overweight participants (body mass index [BMI] < 25 kg/m2) and cumulative bisphosphonate exposure effects. We identified female OAI participants aged ≥50 years and excluded those missing baseline radiograph readings, bisphosphonate use information, or all clinical questionnaire information at baseline. Participants reporting bisphosphonate use (69% alendronate) were propensity-matched 1:1 to non–bisphosphonate users and followed until first radiographic knee OA progression (1-unit increase in Kellgren and Lawrence [KL] grade) or data were censored (first missed visit or end of 2-year follow-up). Discrete-time logistic regression models estimated hazard ratios (HRs) between bisphosphonate users versus nonusers, with an interaction term for baseline KL grade (KL <2 or KL ≥2). We identified 1977 eligible women (n = 346 bisphosphonate users). Propensity-matched results indicated that bisphosphonate users with KL grade <2 were protected against progression (HRKL<2 0.53; 95% CI, 0.35 to 0.79), while bisphosphonate use was not associated with radiographic progression in those with KL grade ≥2 (HRKL≥2 1.06; 95% CI, 0.83 to 1.35). When restricting analyses to those with BMI <25 kg/m2, effects were strengthened (HRKL<2 0.49 [95% CI, 0.26 to 0.92]; HRKL≥2 0.69 [95% CI, 0.33 to 1.26]). Duration of bisphosphonate use had no effect on progression, though sample size was limited. Bisphosphonate therapy may be protective against radiographic knee OA progression in early-stage patients, particularly those who are non-overweight, but less so for those with more advanced disease or more weight-bearing joint stress. © 2020 American Society for Bone and Mineral Research (ASBMR). 相似文献
6.
Parents’ knowledge,attitudes, use of pain relief methods and satisfaction related to their children's postoperative pain management: a descriptive correlational study 下载免费PDF全文
7.
8.
The reliability and validity of the pain items of the Hong Kong version interRAI community health assessment for community‐dwelling elders in Hong Kong 下载免费PDF全文
Justina YW Liu PhD RN Iris Chi DSW Kin‐Sun Chan PhD Claudia KY Lai PhD RN Angela YM Leung PhD RN 《Journal of clinical nursing》2015,24(15-16):2352-2354
9.
10.